Evidence map›Paper›PMID 21393480›Full record

ArticleBlood2011

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Hal E Broxmeyer, Man-Ryul Lee, Giao Hangoc, Scott Cooper, Nutan Prasain, Young-June Kim, Coleen Mallett, Zhaohui Ye, Scott Witting, Kenneth Cornetta and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 172 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. How old is too old?World journal of stem cells · 2020
    Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hal E BroxmeyerDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA. hbroxmey@iupui.edu
Man-Ryul Lee
Giao Hangoc
Scott Cooper
Nutan Prasain
Young-June Kim
Coleen Mallett
Zhaohui Ye
Scott Witting
Kenneth Cornetta
Linzhao Cheng
Mervin C Yoder
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · USJohns Hopkins University · US

Funding

VectorP01HL053586 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CLAPP, DAVID W · 1995 to 2009
$16.0M
TRAINING PROGRAM IN HEMATOLOGYT32HL007525 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ROBERT A BRODSKY · 1985 to 2026
$6.2M
MECHANISMS OF SYNERGISTIC REGULATION OF STEM/PROGENITORSR01HL056416 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BROXMEYER, HAL E. · 1996 to 2017
$6.0M
Cytokine Enhancement of Myeloid Progenitor Cell SurvivalR01HL067384 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BROXMEYER, HAL E. · 2001 to 2014
$4.6M
Human embryonic stem (ES) and embroyonic germ (EG) cells to blood and immune cellR01HL073781 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CHENG, LINZHAO · 2003 to 2013
$4.2M
National Gene Vector Biorespository and Coordinating Center at Indiana UniversityP40RR024928 · NCRR · INDIANA UNIVERSITY INDIANAPOLIS · PI CORNETTA, KENNETH · 2008 to 2011
$4.0M
New Faculty Recruitment to the Indiana University Gene Therapy ProgramP30HL101337 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CORNETTA, KENNETH · 2009 to 2010
$697k
NCRR NIH HHS P40 RR024928NCRR NIH HHS P40RR024928NHLBI NIH HHS HL007525NHLBI NIH HHS P01 HL053586NHLBI NIH HHS P30 HL101337NHLBI NIH HHS R01 HL056416NHLBI NIH HHS R01 HL067384NHLBI NIH HHS R01 HL073781NHLBI NIH HHS R01 HL56416NHLBI NIH HHS R01 HL67384NHLBI NIH HHS T32 HL007525
6 · The paper itself

Abstract

Cryopreservation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) is crucial for cord blood (CB) banking and transplantation. We evaluated recovery of functional HPC cryopreserved as mononuclear or unseparated cells for up to 23.5 years compared with prefreeze values of the same CB units. Highly efficient recovery (80%-100%) was apparent for granulocyte-macrophage and multipotential hematopoietic progenitors, although some collections had reproducible low recovery. Proliferative potential, response to multiple cytokines, and replating of HPC colonies was extensive. CD34(+) cells isolated from CB cryopreserved for up to 21 years had long-term (≥ 6 month) engrafting capability in primary and secondary immunodeficient mice reflecting recovery of long-term repopulating, self-renewing HSCs. We recovered functionally responsive CD4(+) and CD8(+) T lymphocytes, generated induced pluripotent stem (iPS) cells with differentiation representing all 3 germ cell lineages in vitro and in vivo, and detected high proliferative endothelial colony forming cells, results of relevance to CB biology and banking.

Indexed as

Blood PreservationCryopreservationAnimalsColony-Forming Units AssayEndothelial CellsFetal BloodHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansInduced Pluripotent Stem CellsInfant, NewbornInterleukin Receptor Common gamma SubunitIn Vitro TechniquesLymphocyte ActivationMiceMice, Inbred NODIl2rg protein, mouseInterleukin Receptor Common gamma Subunit

Identifiers

PMID21393480
PMCPMC3100689
OpenAlexW2170923159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.